401k Plan data: ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST plan

ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST 401k Plan overview

Plan Name	ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST
Plan identification number	001

ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Plan provides for automatic enrollment in plan that has employee contributions deducted from payroll.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
Plan sponsor(s) received services of leased employees, as defined in Code section 414(n), during the plan year.

401k Sponsoring company profile

ADAMAS PHARMACEUTICALS, INC. has sponsored the creation of one or more 401k plans.

Company Name: ADAMAS PHARMACEUTICALS, INC.

Employer identification number (EIN): 421560076

NAIC Classification: 325500

Form 5500 Filing Information

Submission information for form 5500 for 401k plan ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2022-01-01
001 2022-01-01
001 2021-01-01
001 2021-01-01
001 2021-01-01
001 2020-01-01
001 2020-01-01
001 2020-01-01
001 2019-01-01
001 2018-01-01
001 2017-01-01 MARCY WEBSTER 2018-07-11
001 2016-01-01 DEBORAH FOY 2017-07-27
001 2015-01-01 DEBORAH FOY 2016-07-21
001 2014-01-01 DEBORAH FOY 2015-07-23 DEBORAH FOY 2015-07-23
001 2013-01-01 DEBORAH FOY 2014-07-29 DEBORAH FOY 2014-07-29
001 2012-01-01 DEBORAH FOY 2013-07-26 DEBORAH FOY 2013-07-26
001 2011-01-01 ANTHONY RIMAC 2012-07-25 ANTHONY RIMAC 2012-07-25
001 2010-01-01 DEBORAH FOY 2011-07-28 DEBORAH FOY 2011-07-28

Plan id#	Filing Submission Date	Name of Administrator	Date Administrator Signed	Name of Company Sponsor	Date Sponsor Signed
001	2022-01-01
001	2022-01-01
001	2021-01-01
001	2021-01-01
001	2021-01-01
001	2020-01-01
001	2020-01-01
001	2020-01-01
001	2019-01-01
001	2018-01-01
001	2017-01-01	MARCY WEBSTER	2018-07-11
001	2016-01-01	DEBORAH FOY	2017-07-27
001	2015-01-01	DEBORAH FOY	2016-07-21
001	2014-01-01	DEBORAH FOY	2015-07-23	DEBORAH FOY	2015-07-23
001	2013-01-01	DEBORAH FOY	2014-07-29	DEBORAH FOY	2014-07-29
001	2012-01-01	DEBORAH FOY	2013-07-26	DEBORAH FOY	2013-07-26
001	2011-01-01	ANTHONY RIMAC	2012-07-25	ANTHONY RIMAC	2012-07-25
001	2010-01-01	DEBORAH FOY	2011-07-28	DEBORAH FOY	2011-07-28

Plan Statistics for ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST

401k plan membership statisitcs for ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST

Measure Date Value
2022: ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST 2022 401k membership
Total participants, beginning-of-year 2022-01-01 216
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 0
Number of retired or separated participants receiving benefits 2022-01-01 0
Number of other retired or separated participants entitled to future benefits 2022-01-01 0
Total of all active and inactive participants 2022-01-01 0
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 0
Total participants 2022-01-01 0
Number of participants with account balances 2022-01-01 0
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 0
2021: ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST 2021 401k membership
Total participants, beginning-of-year 2021-01-01 193
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 142
Number of retired or separated participants receiving benefits 2021-01-01 1
Number of other retired or separated participants entitled to future benefits 2021-01-01 73
Total of all active and inactive participants 2021-01-01 216
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 0
Total participants 2021-01-01 216
Number of participants with account balances 2021-01-01 212
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 5
2020: ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST 2020 401k membership
Total participants, beginning-of-year 2020-01-01 207
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 137
Number of retired or separated participants receiving benefits 2020-01-01 0
Number of other retired or separated participants entitled to future benefits 2020-01-01 55
Total of all active and inactive participants 2020-01-01 192
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 0
Total participants 2020-01-01 192
Number of participants with account balances 2020-01-01 189
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 1
2019: ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST 2019 401k membership
Total participants, beginning-of-year 2019-01-01 195
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 136
Number of retired or separated participants receiving benefits 2019-01-01 12
Number of other retired or separated participants entitled to future benefits 2019-01-01 59
Total of all active and inactive participants 2019-01-01 207
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 0
Total participants 2019-01-01 207
Number of participants with account balances 2019-01-01 202
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 12
2018: ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST 2018 401k membership
Total participants, beginning-of-year 2018-01-01 168
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 157
Number of retired or separated participants receiving benefits 2018-01-01 2
Number of other retired or separated participants entitled to future benefits 2018-01-01 32
Total of all active and inactive participants 2018-01-01 191
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 0
Total participants 2018-01-01 191
Number of participants with account balances 2018-01-01 183
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 3

Measure	Date	Value
2022: ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST 2022 401k membership
Total participants, beginning-of-year	2022-01-01	216
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	0
Number of retired or separated participants receiving benefits	2022-01-01	0
Number of other retired or separated participants entitled to future benefits	2022-01-01	0
Total of all active and inactive participants	2022-01-01	0
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	0
Total participants	2022-01-01	0
Number of participants with account balances	2022-01-01	0
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	0
2021: ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST 2021 401k membership
Total participants, beginning-of-year	2021-01-01	193
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	142
Number of retired or separated participants receiving benefits	2021-01-01	1
Number of other retired or separated participants entitled to future benefits	2021-01-01	73
Total of all active and inactive participants	2021-01-01	216
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	0
Total participants	2021-01-01	216
Number of participants with account balances	2021-01-01	212
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	5
2020: ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST 2020 401k membership
Total participants, beginning-of-year	2020-01-01	207
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	137
Number of retired or separated participants receiving benefits	2020-01-01	0
Number of other retired or separated participants entitled to future benefits	2020-01-01	55
Total of all active and inactive participants	2020-01-01	192
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	0
Total participants	2020-01-01	192
Number of participants with account balances	2020-01-01	189
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	1
2019: ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST 2019 401k membership
Total participants, beginning-of-year	2019-01-01	195
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	136
Number of retired or separated participants receiving benefits	2019-01-01	12
Number of other retired or separated participants entitled to future benefits	2019-01-01	59
Total of all active and inactive participants	2019-01-01	207
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	0
Total participants	2019-01-01	207
Number of participants with account balances	2019-01-01	202
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	12
2018: ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST 2018 401k membership
Total participants, beginning-of-year	2018-01-01	168
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	157
Number of retired or separated participants receiving benefits	2018-01-01	2
Number of other retired or separated participants entitled to future benefits	2018-01-01	32
Total of all active and inactive participants	2018-01-01	191
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	0
Total participants	2018-01-01	191
Number of participants with account balances	2018-01-01	183
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	3

Financial Data on ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST

Measure	Date	Value
2022 : ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST 2022 401k financial data
Unrealized appreciation/depreciation of real estate assets	2022-01-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2022-01-31	$0
Total unrealized appreciation/depreciation of assets	2022-01-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-01-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-01-31	$0
Expenses. Interest paid	2022-01-31	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2022-01-31	$0
Total income from all sources (including contributions)	2022-01-31	$-334,860
Total loss/gain on sale of assets	2022-01-31	$0
Total of all expenses incurred	2022-01-31	$8,018,392
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-01-31	$8,013,113
Expenses. Certain deemed distributions of participant loans	2022-01-31	$0
Value of total corrective distributions	2022-01-31	$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-01-31	$24,341
Value of total assets at end of year	2022-01-31	$0
Value of total assets at beginning of year	2022-01-31	$8,353,252
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-01-31	$5,279
Total income from rents	2022-01-31	$0
Total interest from all sources	2022-01-31	$-242
Total dividends received (eg from common stock, registered investment company shares)	2022-01-31	$76
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-01-31	Yes
Value of any plan assets that reverted to the employer resulting from resoluton to terminate the plan	2022-01-31	$0
Total dividends received from registered investment company shares (eg mutual funds)	2022-01-31	$76
Assets. Real estate other than employer real property at end of year	2022-01-31	$0
Assets. Real estate other than employer real property at beginning of year	2022-01-31	$0
Administrative expenses professional fees incurred	2022-01-31	$0
Assets. Corporate prefeered stocks other than exployer securities at end of year	2022-01-31	$0
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2022-01-31	$0
Was this plan covered by a fidelity bond	2022-01-31	Yes
Value of fidelity bond cover	2022-01-31	$500,000
If this is an individual account plan, was there a blackout period	2022-01-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2022-01-31	$0
Were there any nonexempt tranactions with any party-in-interest	2022-01-31	No
Contributions received from participants	2022-01-31	$0
Participant contributions at end of year	2022-01-31	$0
Participant contributions at beginning of year	2022-01-31	$37,294
Participant contributions at end of year	2022-01-31	$0
Participant contributions at beginning of year	2022-01-31	$0
Assets. Other investments not covered elsewhere at end of year	2022-01-31	$0
Assets. Other investments not covered elsewhere at beginning of year	2022-01-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2022-01-31	$0
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2022-01-31	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2022-01-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2022-01-31	$0
Assets. Loans (other than to participants) at end of year	2022-01-31	$0
Assets. Loans (other than to participants) at beginning of year	2022-01-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2022-01-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2022-01-31	$0
Other income not declared elsewhere	2022-01-31	$0
Administrative expenses (other) incurred	2022-01-31	$0
Total non interest bearing cash at end of year	2022-01-31	$0
Total non interest bearing cash at beginning of year	2022-01-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-01-31	No
Income. Non cash contributions	2022-01-31	$0
Value of net income/loss	2022-01-31	$-8,353,252
Value of net assets at end of year (total assets less liabilities)	2022-01-31	$0
Value of net assets at beginning of year (total assets less liabilities)	2022-01-31	$8,353,252
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-01-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-01-31	No
Were any leases to which the plan was party in default or uncollectible	2022-01-31	No
Assets. partnership/joint venture interests at end of year	2022-01-31	$0
Assets. partnership/joint venture interests at beginning of year	2022-01-31	$0
Investment advisory and management fees	2022-01-31	$312
Value of interest in registered invesment companies (eg mutual funds) at end of year	2022-01-31	$0
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2022-01-31	$8,236,314
Interest on participant loans	2022-01-31	$-279
Income. Interest from loans (other than to participants)	2022-01-31	$0
Interest earned on other investments	2022-01-31	$37
Income. Interest from US Government securities	2022-01-31	$0
Income. Interest from corporate debt instruments	2022-01-31	$0
Value of interest in master investment trust accounts at end of year	2022-01-31	$0
Value of interest in master investment trust accounts at beginning of year	2022-01-31	$0
Value of interest in common/collective trusts at end of year	2022-01-31	$0
Value of interest in common/collective trusts at beginning of year	2022-01-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2022-01-31	$0
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2022-01-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2022-01-31	$0
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2022-01-31	$0
Assets. Value of investments in 103.12 investment entities at end of year	2022-01-31	$0
Assets. Value of investments in 103.12 investment entities at beginning of year	2022-01-31	$0
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2022-01-31	$0
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2022-01-31	$79,644
Expenses. Payments to insurance carriers foe the provision of benefits	2022-01-31	$0
Asset value of US Government securities at end of year	2022-01-31	$0
Asset value of US Government securities at beginning of year	2022-01-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2022-01-31	$-359,035
Net investment gain/loss from pooled separate accounts	2022-01-31	$0
Net investment gain or loss from common/collective trusts	2022-01-31	$0
Net gain/loss from 103.12 investment entities	2022-01-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-01-31	No
Was there a failure to transmit to the plan any participant contributions	2022-01-31	No
Has the plan failed to provide any benefit when due under the plan	2022-01-31	No
Assets. Invements in employer securities at end of year	2022-01-31	$0
Assets. Invements in employer securities at beginning of year	2022-01-31	$0
Assets. Value of employer real property at end of year	2022-01-31	$0
Assets. Value of employer real property at beginning of year	2022-01-31	$0
Contributions received in cash from employer	2022-01-31	$24,341
Employer contributions (assets) at end of year	2022-01-31	$0
Employer contributions (assets) at beginning of year	2022-01-31	$0
Income. Dividends from preferred stock	2022-01-31	$0
Income. Dividends from common stock	2022-01-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-01-31	$8,013,113
Asset. Corporate debt instrument preferred debt at end of year	2022-01-31	$0
Asset. Corporate debt instrument preferred debt at beginning of year	2022-01-31	$0
Asset. Corporate debt instrument debt (other) at end of year	2022-01-31	$0
Asset. Corporate debt instrument debt (other) at beginning of year	2022-01-31	$0
Contract administrator fees	2022-01-31	$4,967
Assets. Corporate common stocks other than exployer securities at end of year	2022-01-31	$0
Assets. Corporate common stocks other than exployer securities at beginning of year	2022-01-31	$0
Liabilities. Value of benefit claims payable at end of year	2022-01-31	$0
Liabilities. Value of benefit claims payable at beginning of year	2022-01-31	$0
Assets. Value of buildings and other operty used in plan operation at end of year	2022-01-31	$0
Assets. Value of buildings and other operty used in plan operation at beginning of year	2022-01-31	$0
Did the plan have assets held for investment	2022-01-31	No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-01-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-01-31	Yes
Aggregate proceeds on sale of assets	2022-01-31	$0
Aggregate carrying amount (costs) on sale of assets	2022-01-31	$0
Liabilities. Value of acquisition indebtedness at end of year	2022-01-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2022-01-31	$0
Opinion of an independent qualified public accountant for this plan	2022-01-31	Unqualified
Accountancy firm name	2022-01-31	BBP LLP
Accountancy firm EIN	2022-01-31	814234542
2021 : ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST 2021 401k financial data
Unrealized appreciation/depreciation of real estate assets	2021-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2021-12-31	$0
Total unrealized appreciation/depreciation of assets	2021-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Expenses. Interest paid	2021-12-31	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2021-12-31	$0
Total income from all sources (including contributions)	2021-12-31	$4,342,730
Total loss/gain on sale of assets	2021-12-31	$0
Total of all expenses incurred	2021-12-31	$6,572,743
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$6,548,494
Expenses. Certain deemed distributions of participant loans	2021-12-31	$0
Value of total corrective distributions	2021-12-31	$6,039
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$2,988,797
Value of total assets at end of year	2021-12-31	$8,353,252
Value of total assets at beginning of year	2021-12-31	$10,583,265
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$18,210
Total income from rents	2021-12-31	$0
Total interest from all sources	2021-12-31	$4,713
Total dividends received (eg from common stock, registered investment company shares)	2021-12-31	$64,075
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	Yes
Value of any plan assets that reverted to the employer resulting from resoluton to terminate the plan	2021-12-31	$0
Total dividends received from registered investment company shares (eg mutual funds)	2021-12-31	$64,075
Assets. Real estate other than employer real property at end of year	2021-12-31	$0
Assets. Real estate other than employer real property at beginning of year	2021-12-31	$0
Administrative expenses professional fees incurred	2021-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at end of year	2021-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2021-12-31	$0
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$500,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2021-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$2,175,253
Participant contributions at end of year	2021-12-31	$37,294
Participant contributions at beginning of year	2021-12-31	$54,237
Participant contributions at end of year	2021-12-31	$0
Participant contributions at beginning of year	2021-12-31	$61,208
Assets. Other investments not covered elsewhere at end of year	2021-12-31	$0
Assets. Other investments not covered elsewhere at beginning of year	2021-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2021-12-31	$15,104
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2021-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2021-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2021-12-31	$0
Assets. Loans (other than to participants) at end of year	2021-12-31	$0
Assets. Loans (other than to participants) at beginning of year	2021-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2021-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2021-12-31	$0
Other income not declared elsewhere	2021-12-31	$-3,480
Administrative expenses (other) incurred	2021-12-31	$0
Total non interest bearing cash at end of year	2021-12-31	$0
Total non interest bearing cash at beginning of year	2021-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Income. Non cash contributions	2021-12-31	$0
Value of net income/loss	2021-12-31	$-2,230,013
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$8,353,252
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$10,583,265
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Assets. partnership/joint venture interests at end of year	2021-12-31	$0
Assets. partnership/joint venture interests at beginning of year	2021-12-31	$0
Investment advisory and management fees	2021-12-31	$229
Value of interest in registered invesment companies (eg mutual funds) at end of year	2021-12-31	$8,236,314
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-12-31	$10,444,179
Interest on participant loans	2021-12-31	$4,126
Income. Interest from loans (other than to participants)	2021-12-31	$0
Interest earned on other investments	2021-12-31	$587
Income. Interest from US Government securities	2021-12-31	$0
Income. Interest from corporate debt instruments	2021-12-31	$0
Value of interest in master investment trust accounts at end of year	2021-12-31	$0
Value of interest in master investment trust accounts at beginning of year	2021-12-31	$0
Value of interest in common/collective trusts at end of year	2021-12-31	$0
Value of interest in common/collective trusts at beginning of year	2021-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2021-12-31	$0
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2021-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2021-12-31	$0
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2021-12-31	$0
Assets. Value of investments in 103.12 investment entities at end of year	2021-12-31	$0
Assets. Value of investments in 103.12 investment entities at beginning of year	2021-12-31	$0
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2021-12-31	$79,644
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2021-12-31	$11,289
Expenses. Payments to insurance carriers foe the provision of benefits	2021-12-31	$0
Asset value of US Government securities at end of year	2021-12-31	$0
Asset value of US Government securities at beginning of year	2021-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-12-31	$1,288,625
Net investment gain/loss from pooled separate accounts	2021-12-31	$0
Net investment gain or loss from common/collective trusts	2021-12-31	$0
Net gain/loss from 103.12 investment entities	2021-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	No
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Assets. Invements in employer securities at end of year	2021-12-31	$0
Assets. Invements in employer securities at beginning of year	2021-12-31	$0
Assets. Value of employer real property at end of year	2021-12-31	$0
Assets. Value of employer real property at beginning of year	2021-12-31	$0
Contributions received in cash from employer	2021-12-31	$798,440
Employer contributions (assets) at end of year	2021-12-31	$0
Employer contributions (assets) at beginning of year	2021-12-31	$12,352
Income. Dividends from preferred stock	2021-12-31	$0
Income. Dividends from common stock	2021-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$6,548,494
Asset. Corporate debt instrument preferred debt at end of year	2021-12-31	$0
Asset. Corporate debt instrument preferred debt at beginning of year	2021-12-31	$0
Asset. Corporate debt instrument debt (other) at end of year	2021-12-31	$0
Asset. Corporate debt instrument debt (other) at beginning of year	2021-12-31	$0
Contract administrator fees	2021-12-31	$17,981
Assets. Corporate common stocks other than exployer securities at end of year	2021-12-31	$0
Assets. Corporate common stocks other than exployer securities at beginning of year	2021-12-31	$0
Liabilities. Value of benefit claims payable at end of year	2021-12-31	$0
Liabilities. Value of benefit claims payable at beginning of year	2021-12-31	$0
Assets. Value of buildings and other operty used in plan operation at end of year	2021-12-31	$0
Assets. Value of buildings and other operty used in plan operation at beginning of year	2021-12-31	$0
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Aggregate proceeds on sale of assets	2021-12-31	$0
Aggregate carrying amount (costs) on sale of assets	2021-12-31	$0
Liabilities. Value of acquisition indebtedness at end of year	2021-12-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2021-12-31	$0
Opinion of an independent qualified public accountant for this plan	2021-12-31	Unqualified
Accountancy firm name	2021-12-31	BBP LLP
Accountancy firm EIN	2021-12-31	814234542
2020 : ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST 2020 401k financial data
Unrealized appreciation/depreciation of real estate assets	2020-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2020-12-31	$0
Total unrealized appreciation/depreciation of assets	2020-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Expenses. Interest paid	2020-12-31	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2020-12-31	$0
Total income from all sources (including contributions)	2020-12-31	$3,902,021
Total loss/gain on sale of assets	2020-12-31	$0
Total of all expenses incurred	2020-12-31	$2,853,911
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$2,782,839
Expenses. Certain deemed distributions of participant loans	2020-12-31	$0
Value of total corrective distributions	2020-12-31	$10,424
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$2,562,752
Value of total assets at end of year	2020-12-31	$10,509,705
Value of total assets at beginning of year	2020-12-31	$9,461,595
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$60,648
Total income from rents	2020-12-31	$0
Total interest from all sources	2020-12-31	$7,789
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$8,062
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2020-12-31	$8,062
Assets. Real estate other than employer real property at end of year	2020-12-31	$0
Assets. Real estate other than employer real property at beginning of year	2020-12-31	$0
Administrative expenses professional fees incurred	2020-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at end of year	2020-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2020-12-31	$0
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$500,000
If this is an individual account plan, was there a blackout period	2020-12-31	Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2020-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Contributions received from participants	2020-12-31	$1,752,987
Participant contributions at end of year	2020-12-31	$54,237
Participant contributions at beginning of year	2020-12-31	$35,452
Participant contributions at end of year	2020-12-31	$0
Participant contributions at beginning of year	2020-12-31	$50,393
Assets. Other investments not covered elsewhere at end of year	2020-12-31	$0
Assets. Other investments not covered elsewhere at beginning of year	2020-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$148,092
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2020-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2020-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2020-12-31	$0
Assets. Loans (other than to participants) at end of year	2020-12-31	$0
Assets. Loans (other than to participants) at beginning of year	2020-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2020-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2020-12-31	$0
Other income not declared elsewhere	2020-12-31	$50,247
Administrative expenses (other) incurred	2020-12-31	$0
Total non interest bearing cash at end of year	2020-12-31	$0
Total non interest bearing cash at beginning of year	2020-12-31	$102
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Income. Non cash contributions	2020-12-31	$0
Value of net income/loss	2020-12-31	$1,048,110
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$10,509,705
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$9,461,595
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Assets. partnership/joint venture interests at end of year	2020-12-31	$0
Assets. partnership/joint venture interests at beginning of year	2020-12-31	$0
Investment advisory and management fees	2020-12-31	$12,171
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-12-31	$10,444,179
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-12-31	$3,436,288
Interest on participant loans	2020-12-31	$3,924
Income. Interest from loans (other than to participants)	2020-12-31	$0
Interest earned on other investments	2020-12-31	$3,865
Income. Interest from US Government securities	2020-12-31	$0
Income. Interest from corporate debt instruments	2020-12-31	$0
Value of interest in master investment trust accounts at end of year	2020-12-31	$0
Value of interest in master investment trust accounts at beginning of year	2020-12-31	$0
Value of interest in common/collective trusts at end of year	2020-12-31	$0
Value of interest in common/collective trusts at beginning of year	2020-12-31	$5,917,530
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2020-12-31	$0
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2020-12-31	$137
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2020-12-31	$137
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2020-12-31	$0
Assets. Value of investments in 103.12 investment entities at end of year	2020-12-31	$0
Assets. Value of investments in 103.12 investment entities at beginning of year	2020-12-31	$0
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2020-12-31	$11,289
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2020-12-31	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2020-12-31	$0
Asset value of US Government securities at end of year	2020-12-31	$0
Asset value of US Government securities at beginning of year	2020-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-12-31	$747,962
Net investment gain/loss from pooled separate accounts	2020-12-31	$0
Net investment gain or loss from common/collective trusts	2020-12-31	$525,209
Net gain/loss from 103.12 investment entities	2020-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	No
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Assets. Invements in employer securities at end of year	2020-12-31	$0
Assets. Invements in employer securities at beginning of year	2020-12-31	$0
Assets. Value of employer real property at end of year	2020-12-31	$0
Assets. Value of employer real property at beginning of year	2020-12-31	$0
Contributions received in cash from employer	2020-12-31	$661,673
Employer contributions (assets) at end of year	2020-12-31	$0
Employer contributions (assets) at beginning of year	2020-12-31	$21,693
Income. Dividends from preferred stock	2020-12-31	$0
Income. Dividends from common stock	2020-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$2,782,839
Asset. Corporate debt instrument preferred debt at end of year	2020-12-31	$0
Asset. Corporate debt instrument preferred debt at beginning of year	2020-12-31	$0
Asset. Corporate debt instrument debt (other) at end of year	2020-12-31	$0
Asset. Corporate debt instrument debt (other) at beginning of year	2020-12-31	$0
Contract administrator fees	2020-12-31	$48,477
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2020-12-31	Yes
Assets. Corporate common stocks other than exployer securities at end of year	2020-12-31	$0
Assets. Corporate common stocks other than exployer securities at beginning of year	2020-12-31	$0
Liabilities. Value of benefit claims payable at end of year	2020-12-31	$0
Liabilities. Value of benefit claims payable at beginning of year	2020-12-31	$0
Assets. Value of buildings and other operty used in plan operation at end of year	2020-12-31	$0
Assets. Value of buildings and other operty used in plan operation at beginning of year	2020-12-31	$0
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Aggregate proceeds on sale of assets	2020-12-31	$0
Aggregate carrying amount (costs) on sale of assets	2020-12-31	$0
Liabilities. Value of acquisition indebtedness at end of year	2020-12-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2020-12-31	$0
Opinion of an independent qualified public accountant for this plan	2020-12-31	Disclaimer
Accountancy firm name	2020-12-31	BBP LLP
Accountancy firm EIN	2020-12-31	814234542
2019 : ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST 2019 401k financial data
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total income from all sources (including contributions)	2019-12-31	$4,769,707
Total loss/gain on sale of assets	2019-12-31	$0
Total of all expenses incurred	2019-12-31	$1,433,281
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$1,386,476
Value of total corrective distributions	2019-12-31	$4,667
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$3,241,197
Value of total assets at end of year	2019-12-31	$9,461,595
Value of total assets at beginning of year	2019-12-31	$6,125,169
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$42,138
Total interest from all sources	2019-12-31	$1,503
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$144,417
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$144,417
Administrative expenses professional fees incurred	2019-12-31	$0
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$500,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$1,962,822
Participant contributions at end of year	2019-12-31	$35,452
Participant contributions at beginning of year	2019-12-31	$28,891
Participant contributions at end of year	2019-12-31	$50,393
Participant contributions at beginning of year	2019-12-31	$58,538
Assets. Other investments not covered elsewhere at end of year	2019-12-31	$0
Assets. Other investments not covered elsewhere at beginning of year	2019-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$509,258
Total non interest bearing cash at end of year	2019-12-31	$102
Total non interest bearing cash at beginning of year	2019-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Income. Non cash contributions	2019-12-31	$0
Value of net income/loss	2019-12-31	$3,336,426
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$9,461,595
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$6,125,169
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Investment advisory and management fees	2019-12-31	$30,193
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$3,436,288
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$5,425,948
Interest on participant loans	2019-12-31	$1,503
Value of interest in common/collective trusts at end of year	2019-12-31	$5,917,530
Value of interest in common/collective trusts at beginning of year	2019-12-31	$599,943
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2019-12-31	$137
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2019-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2019-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$1,380,454
Net investment gain or loss from common/collective trusts	2019-12-31	$2,136
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$769,117
Employer contributions (assets) at end of year	2019-12-31	$21,693
Employer contributions (assets) at beginning of year	2019-12-31	$11,849
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$1,386,476
Contract administrator fees	2019-12-31	$11,945
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	BPM LLP
Accountancy firm EIN	2019-12-31	814234542
2018 : ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST 2018 401k financial data
Total unrealized appreciation/depreciation of assets	2018-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total income from all sources (including contributions)	2018-12-31	$2,402,847
Total loss/gain on sale of assets	2018-12-31	$0
Total of all expenses incurred	2018-12-31	$1,539,589
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$1,505,581
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$2,710,629
Value of total assets at end of year	2018-12-31	$6,125,169
Value of total assets at beginning of year	2018-12-31	$5,261,911
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$34,008
Total interest from all sources	2018-12-31	$1,593
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$258,103
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2018-12-31	$258,103
Administrative expenses professional fees incurred	2018-12-31	$0
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$500,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$1,861,163
Participant contributions at end of year	2018-12-31	$28,891
Participant contributions at beginning of year	2018-12-31	$43,417
Participant contributions at end of year	2018-12-31	$58,538
Participant contributions at beginning of year	2018-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$331,704
Liabilities. Value of operating payables at end of year	2018-12-31	$0
Liabilities. Value of operating payables at beginning of year	2018-12-31	$0
Total non interest bearing cash at end of year	2018-12-31	$0
Total non interest bearing cash at beginning of year	2018-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$863,258
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$6,125,169
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$5,261,911
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Investment advisory and management fees	2018-12-31	$25,644
Value of interest in registered invesment companies (eg mutual funds) at end of year	2018-12-31	$5,425,948
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2018-12-31	$4,769,002
Interest on participant loans	2018-12-31	$1,593
Value of interest in common/collective trusts at end of year	2018-12-31	$599,943
Value of interest in common/collective trusts at beginning of year	2018-12-31	$449,492
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2018-12-31	$-576,999
Net investment gain or loss from common/collective trusts	2018-12-31	$9,521
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$517,762
Employer contributions (assets) at end of year	2018-12-31	$11,849
Employer contributions (assets) at beginning of year	2018-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$1,505,581
Contract administrator fees	2018-12-31	$8,364
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	BPM LLP
Accountancy firm EIN	2018-12-31	814234542

Form 5500 Responses for ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST

2022: ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	Submission has been amended	No
2022-01-01	This submission is the final filing	Yes
2022-01-01	This return/report is a short plan year return/report (less than 12 months)	Yes
2022-01-01	Plan is a collectively bargained plan	No
2022-01-01	Plan funding arrangement – Insurance	Yes
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement – Insurance	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	Submission has been amended	No
2021-01-01	This submission is the final filing	No
2021-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2021-01-01	Plan is a collectively bargained plan	No
2021-01-01	Plan funding arrangement – Insurance	Yes
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement – Insurance	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Submission has been amended	Yes
2020-01-01	This submission is the final filing	No
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Insurance	Yes
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement – Insurance	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: ADAMAS PHARMACEUTICALS, INC. RETIREMENT TRUST 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Submission has been amended	No
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	No
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes

Insurance Providers Used on plan

GREAT-WEST LIFE & ANNUITY INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 68322 )

Policy contract number

510487-01

Policy instance

Insurance contract or identification number	510487-01
Number of Individuals Covered	0
Insurance policy start date	2022-01-01
Insurance policy end date	2022-01-31
Are there contracts with allocated funds for individual policies?	0
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

GREAT-WEST LIFE & ANNUITY INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 68322 )

Policy contract number

510487-01

Policy instance

Insurance contract or identification number	510487-01
Number of Individuals Covered	1
Insurance policy start date	2021-01-01
Insurance policy end date	2021-12-31
Are there contracts with allocated funds for individual policies?	0
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

GREAT-WEST LIFE & ANNUITY INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 68322 )

Policy contract number

510487-01

Policy instance

Insurance contract or identification number	510487-01
Number of Individuals Covered	0
Insurance policy start date	2020-01-01
Insurance policy end date	2020-12-31
Are there contracts with allocated funds for individual policies?	0
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	ADAMAS PHARMACEUTICALS, INC.
Employer identification number (EIN):	421560076
NAIC Classification:	325500